Managing inadequate antidepressant response in depressive illness

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Depression often shows poor response to initial treatments, necessitating further therapeutic strategies.
• Identifying and addressing remedial causes of treatment resistance is crucial for effective management.

Purpose of the Study:

• To systematically assess and outline sequential treatment strategies for depression that does not respond to initial therapies.
• To provide evidence-based recommendations for managing treatment-resistant depression.

Main Methods:

• Primarily based on meta-analyses and randomized controlled trials (RCTs).
• Supplemented with additional relevant data and expert clinical experience.
• Systematic assessment to identify causes of poor treatment response.

Main Results:

• Strongest evidence supports antidepressant augmentation with lithium or second-generation antipsychotics, and adding cognitive behavioral therapy.
• Electroconvulsive therapy is effective for resistant depression but associated with high relapse rates.
• Some strategies like antidepressant combinations or ketamine have inconsistent or limited data; efficacy of neuromodulation techniques is unclear.

Conclusions:

• Planned, sequential treatment trials guided by joint patient-clinician decisions are essential for treatment-resistant depression.
• Further research into glutamate antagonists and non-cognitive behavioral psychological treatments is warranted.
• A deeper understanding of depression's underlying mechanisms may lead to more effective future treatments.